Tissue culture has been used for over 100 years to study cells and responses ex vivo. The convention of this technique is the growth of anchorage dependent cells on the 2-dimensional surface of tissue culture plastic. More recently, there is a growing body of data demonstrating more in vivo-like behaviors of cells grown in 3-dimensional culture systems. This manuscript describes in detail the set-up and operation of a hollow fiber bioreactor system for the in vivo-like culture of mammalian cells. The hollow fiber bioreactor system delivers media to the cells in a manner akin to the delivery of blood through the capillary networks in vivo. The system is designed to fit onto the shelf of a standard CO 2 incubator and is simple enough to be set-up by any competent cell biologist with a good understanding of aseptic technique. The systems utility is demonstrated by culturing the hepatocarcinoma cell line HepG2/C3A for 7 days. Further to this and in line with other published reports on the functionality of cells grown in 3-dimensional culture systems the cells are shown to possess increased albumin production (an important hepatic function) when compared to standard 2-dimensional tissue culture.
Introduction
Tissue culture is an established technique for the growth and/or maintenance of cells that has been utilized for over 100 years 1, 2 . The convenience of studying cells and responses ex vivo has far reaching advantages allowing experiments that would otherwise be extremely challenging if not impossible, for example the generation of genetically engineered cell lines and the use of reporter cells in high throughput screening assays 3 . More recently tissue culture has given rise to the field of tissue engineering, for the generation of in vitro models and for regenerative medicine. With these applications, interest in dynamic 3-dimensional (3D) culture systems has grown significantly.
3D culture methods (defined here as a 3D culture substrate and/or the introduction of directional dynamic flow) better recapitulate the architecture of the in vivo cellular environment, important for achieving a more physiological-like function. The ability to extract, grow, differentiate and transplant cells with the aim of repairing diseased and damaged tissue is a field of study that has a huge potential for patient benefit and commercial opportunity. For example the use of autologous keratinocytes for treating burns (see 4 ) and the use of cell based therapies for the treatment of stroke (see 5 ). Likewise, the market for in vitro models spans drug discovery to stratified medicine applications. The convention in tissue culture is the growth of adherent or anchorage dependent cell types on the 2-dimensional (2D) surface of a tissue culture flask. Whilst currently accepted as the gold standard in a research setting, recent interest in tissue engineering applications has highlighted the fact that current 2D tissue culture environment is inadequate for the required scale-up in cell production 6 .
For adherent cell types a scaffold is required, which will vary depending on end use, in terms of both the chemical composition and mechanical properties. Some systems employ scaffolds as well-plate inserts consisting of highly porous matrix formed from high internal phase emulsion templating (see 7 ) or electrospun fibers (see 8 ) requiring minimum adaptation from conventional 2D culture techniques. Cells can be seeded onto microcarriers of varying compositions and grown in stirred tanks that deliver nutrients and signaling molecules, and carry away waste products (mass transport) through a dynamic well mixed environment 9 . However, these systems are limited in their in vivo-like environment and further improvements can be made with regards to scale-up costs. Hollow fiber bioreactors (HFBs) are a 3D culture system that consist of fibers fixed into a module with cells typically seeded on the outside of the porous fibers and media delivered through the fiber lumen (reviewed in 10 ) ( Figure  1) . HFBs offer an in vivo-like environment with the fibers mimicking blood capillaries and shielding the cells from the shear stresses associated with dynamic media delivery, while allowing defined shear to be applied to cells the via fluid flow through the side ports if desired. This creates a versatile culture system with superior mass transport in which high cell densities can be reached 11 . The HFB system is well suited for the maintenance of anchorage dependent cell types and has been used to culture a variety of cells including rat pancreatic islets of Langerhans , Madin Darby canine kidney cells (MDCK) 15 and Caco-2 cells 16 to name a few.
In addition to the system advantages of mass transfer and scale-up, cells grown in 3D tissue culture systems tend to be more in vivo-like in morphology and more responsive to experimental cues. For example rat primary hepatocytes show a more cuboidal morphology, increased viability, greater induction of cytochrome-P450 enzyme activity and increased sensitivity to paracetamol toxicity when grown in a commercially available polystyrene scaffold compared to cells grown in 2D culture 17 . Using the same scaffold the hepatocarcinoma cell line HepG2 has also been shown to increase albumin production 18 and show a more in vivo-like response to methotrexate compared to 2D cultured cells 19 . Primary human hepatocytes demonstrated delayed dedifferentiation, higher cytochrome-P450 activity and increased clearance for 4/5 compounds tested in a perfusion culture system 20 . Human neural stem cell derived neurons and glia cultured in a commercially available polystyrene scaffold exhibited both high (action potential) and low-frequency (local field potential) spontaneous activity whereas no neuronal activity was detected in the 2D cultured cells 21 . Caco-2 cells demonstrated enhanced differentiation in a HFB compared to 2D culture measured by increased alkaline phosphatase, γ-glutamyltransferase and P-glycoprotein activity and higher expression of F-actin and zona occludens-1 protein 16 . Despite the advantages, the routine culturing of cells in systems other than a 2D tissue culture flask surface is still not practiced in many laboratories, although the number of publications citing 3D cell culture is growing (8-fold increase in the last 10 years. Source: PubMed 'Results by Year' tool probed with '3D culture').
This manuscript describes the set-up and operating conditions of a HFB system for mammalian cell culture and demonstrates its utility in culturing the hepatocarcinoma cell line HepG2/C3A. The aim of this method is to culture the cells in a more in vivo-like culture system that retains enough simplicity to make it amenable to those who are new to 3D culture systems. The rationale behind using HFBs in the application describe here, which is to improve the predictability of liver models is that it is theoretically possible to mimic a hepatic sinusoid within the HFB environment 22 . This is not currently feasible with other culture systems.
Protocol

Fibers
1. Manufacture the fibers by phase inversion spin casting (spinning). Details of this method can be found in 23, 24 . NOTE: For this work the fibers are manufactured in-house using a non-biodegradable proprietary polymer, NMP as the solvent and H 2 O as the non-solvent. Details of other suitable polymers can be found in the discussion. The fibers used in the system described here are 1.05mm outer diameter with a 600-700 µm lumen diameter. The fibers are porous with pore diameters measuring 2.28 µm ± 1.5 µm (mean ± standard deviation). This is designed to separate cells from the media feed in the fiber lumen, replicating the liver sinusoid or vasculature of other tissues. Fibers can also be purchased from membrane suppliers such as Pall.
1. To wash the ethanol out of the system, first turn off the pump and drain the tubing. First, detach the pump tubing from the module adaptor tubing. Hold the module aloft to drain the ethanol out of the fibers and retentate line, back into the reservoir bottle. Remove the side port end cap from the module to drain the ethanol from the module itself, and the permeate line. Reattach the side port end cap.
Reverse the flow of media on the pump to drain the pump tubing and feed line of ethanol. Turn off the pump, and reattach the pump tubing to the module adaptor. 2. Unscrew the ethanol bottle from the lid and replace with a bottle containing 10 ml of cell growth medium (such as EMEM, GMEM, DMEM or RPMI) without serum. Pump the medium through the system at 800 µl/hr until the retentate line is full of media. Clamp the retentate line to force permeation of the media through the fibers to wash the module. Wash for ~2 hr.
Seeding
NOTE: The media and supplements used in this protocol should be those that are established for the desired cell type. Please refer to the literature, the European Collection of Cell Cultures (ECACC) and American Type Culture Collection (ATCC) for further information. Prior to this method cells should be maintained according to established protocols for the desired cell type. For this work the hepatocarcinoma cell line HepG2/C3A subclone were maintained according to the distributors recommendations (ATCC).
NOTE: The seeding protocol presented below also serves to pre-culture the module with cell culture medium prior to cell growth. Should a more extensive pre-culture be required then this should be carried out prior to seeding the module by draining the wash media from the system, replacing with growth media and permeating this through the module for few hours. See section 7.5.2.1 for details on replacing media in the system.
1. Prepare a single cell suspension by trypsinization according to established protocols for the desired cell type. A general protocol for a T75 culture is as follows: NOTE: The number of cells to use in the seeding step should be empirically determined for your desired cell type. The bioreactors described here are seeded at a 35-fold higher cells density (cell/cm 2 ) than used in 2D tissue culture plastic for a 7 day culture. 1. Wash the cells by adding 10 ml phosphate buffered saline (PBS), aspirate, then add 3 ml 0.05% trypsin ethylenediaminetetraacetic acid (EDTA) (enough to cover the cells) and incubate at 37 °C, 5% CO 2 for 5 min. 2. Harvest cells in 7 ml growth media supplemented with 10% fetal bovine serum (FBS) to neutralize the trypsin. Mix well, add 10 µl to the chamber of a hemocytometer and count the cells. Table 1 ) pre-sterilized in 70% ethanol, leaving one side port free. 4. Transfer ~500 µl of the cell suspension (2x10 6 cells) (4.1.4) to the module using an 18 G needle and 1 ml syringe, taking care to avoid bubble formation and not to damage the fibers. 1. Cap the side port using an end cap. Incubate the cells at 37 °C, 5% CO 2 for 2-4 hr with manual turning of the module by 180° every 5 min. Alternatively the modules can be attached to a tube rotator with an intermittent mixing setting ( Table 1) .
5. Following seeding, attach an end cap onto an injection port ( Table 1 ) pre-sterilized in 70% ethanol, and attach this to the PTFE-taped side port. Remove the other side port end cap and slowly drain the cells by injecting air into the attached injection port using a 27 G needle and 1 ml syringe. 1. Replace the injection port with an end cap. Slowly fill the module with media using the free side port and an 18 G needle with a 1 ml syringe. Remove the module end caps and attach the module to the tubing using the module connectors.
6. Replace the wash media bottle with one containing 50 ml growth media and supplements following the procedure detailed in 7.5.2.1. Pump the growth media through the system at 800 µl/hr.
Proliferation
NOTE: The fibers used in the research system described here are set to permeate at ~80 µl/hr, with an 800 µl/hr feed rate.
1. Use the fibers to grow the cells for periods of up to 7 days in a humidified incubator set at 37 °C, 5% CO 2 . NOTE: Monitoring of nutrients and metabolites during the growth phase can provide useful information on the proliferation, metabolic uptake and output of the cells and nutrient and metabolite levels in the media. For example glucose usage and lactate production. Kits are available from various suppliers that can quantitate these factors from media (see Table 1 for those used in this study). Injection ports can be added to the permeate and retentate tubing and media sampled via a 27 G needle and syringe, and media can be sampled from the media reservoir bottle. This gives nutrient and metabolism information for the input and both output streams. Sampling should be carried out in a laminar flow hood. Sterilize injection ports before sampling by holding an ethanol soaked blue roll against the port for >30 sec.
Excision
NOTE: Fibers can be excised from the module at the end of an experiment for analysis.
1. Unplug and drain the HFB. 2. Insert a scalpel/micro knife ( Table 1) blade between the glass and silicone. Turn the module so as to cut away the silicone from the glass.
Repeat this procedure at both ends of the module.
1. Cell numbers NOTE: For the C3A cells used in this study any time points within the 7 day growth period are suitable for use in this calculation as growth rates do not substantially change over the cell densities achieved in this timeframe. 1. After excision (Section 6) dip the fibers into PBS to wash and cut them into a 1.5 ml tube containing 0.5 ml Tris EDTA (TE) buffer. Subject this to two freeze-thaw cycles in a -80 °C freezer. Measure the DNA content using PicoGreen and determine cell numbers by comparing this value to a standard curve made with the desired cell type 26 .
2. Cell proliferation rates 1. Using the cell numbers calculated at two different time points calculate the specific growth rate µ (Equation 1) where Ln(X1) is the natural log of the cell number at the first time point and Ln(X2) is the natural log of the cell number at the second time point. µ=(Ln(X2)-Ln(X1))/time(hr) (1) From this calculate the population doubling times (dT) (Equation 2) where µ is the specific growth rate. dT=Ln2/µ
3. Cell viability 1. After excision (Section 6) dip the fibers into PBS to wash and cut them into a 1.5 ml tube containing 500 µl 0.05% trypsin ethylenediaminetetraacetic acid (EDTA). Incubate at 37 °C for 10 min. 2. Mix and add 10 µl of cell suspension to 10 µl trypan blue. Load 10 µl onto a haemocytometer and count the number of dead (blue) and alive cells. 
Representative Results
Cell seeding is a critical step. The ability of cells to adhere to the fiber in a 3D set-up is considerably less than that seen for 2D tissue culture plastic. This is likely due to the reduced contact time between cell and substrate. In the HFB the cells fall through the module during the static phases of seeding. These are considerably shorter in time compared to the one continuous static phase used in 2D. Cells have to make connections to the substrate in this time. Additionally, due to the curved nature of the fibers there is no flat surface for the cells to rest and make connections like there is in 2D culture. Whilst this can be compounded by the chemistry of the fiber employed we know this not to be the case for the polymer employed in this study (data not shown). Increasing the seeding time and cell seeding density leads to the formation of cell aggregates that fall through the module during the static phases at a faster rate than single cells and further reduces the contact time between cells and substrate. Increasing the time also leads to yellowing of the media as there is a high density of cells and no media exchange during this step. Using the conditions described in Section 4 cell seeding rates of ~15% are consistently achieved with the HepG2/C3A cells ( Figure 5A ). Whilst this may be considered a low fraction there are enough cells to generate well-populated fibers in a matter of days ( Figures 5B and 6) ; following a seven-day proliferation period the cell density reached in the HFB is approaching 3x10
Monitoring of glucose consumption and lactic acid production has been used to tune the media feed rate and media volume in the system. Using 800 µl/hr and a total media volume of 50 ml the glucose and lactic acid levels are maintained above and below (respectively) those seen in standard tissue culture plastic culture.
Albumin secretion is a key liver function carried out by hepatocytes. It is secreted into the serum where it plays several roles in transport and homeostasis. The albumin secretion by cells grown in the HFB is 15-fold higher than that in cells grown on 2D (Figure 7) . This demonstrates the cells are functional in the HFB and at least in the case of albumin secretion, this function is elevated in the HFB. 
Discussion
This manuscript describes the set-up and operation of a hollow fiber bioreactor (HFB) system for mammalian cell culture and its utility is demonstrated in proliferating the hepatocyte cell line HepG2/C3A. The system is designed to fit onto the shelf of a standard incubator and its setup is simple enough to be carried out by any competent cell biologist familiar with aseptic technique.
The fibers used in the research system described here are manufactured in house by phase inversion spin casting (spinning) using a non-biodegradable proprietary polymer. It is possible to make fibers by spinning from a variety of materials suitable for cell culture, both biodegradable and non-biodegradable, for example; polycaprolactone (PCL) 27 , poly-L-lactide acid (PLLA) 28 , poly(lactic-co-glycolic acid) (PLGA) 29 , polysulfone (PSU) 12 and polyetheretherketone (PEEK)
.
The dimensions of the glass modules used here were chosen based on the needs of the current research. Different sizes can be made by any reputable glass blowing company. A consideration in module size is the number of cells, which is linked to the number of fibers in the module and likely flow rates. The more cells there are in the module the higher the flow rates will need to be in order to maintain favorable culture conditions at the outflow end of the bioreactor. This will reach a limit as some point and some trial and error may be required with monitoring of media conditions in the module permeate. Mathematical modelling may provide some insights into the required module dimensions and flow rates 22 .
The dimensions of the apparatus used here is designed to fit onto an incubator shelf. The length of the tubing is dictated by the length needed to reach between the connectors whilst also allowing enough movement of components to allow for set-up and operation. If time course sampling is required, for example in the monitoring of media conditions in the module permeate then injection ports can be added to the retentate and permeate lines to facilitate this.
A prerequisite for any cell culture system is to keep cells alive and in most cases growing. In the light of studies demonstrating a more in vivo-like phenotype in cells grown in 3D culture systems it also seems important to provide an environment that closely mimics the in vivo environment encountered by the cells. This last point is often neglected in 2D cell culture in favor of the convenience this culture system offers. The HFB mimics in vivo capillary networks by delivering nutrients to the cells through the lumen of fibers. The waste products are also removed from the system by the dynamic flow. This creates an in vivo-like system for cell culture and one that closely mimics the in vivo environment seen by hepatocytes, making this system a better choice compared to 2D tissue culture plastic for culturing these cells. This is corroborated by the fact the cells secrete 15-fold the amount of albumin, an important hepatic function, in the HFB culture system compared to those grown on 2D tissue culture plastic.
Whilst the HFB system is suited to most if not all anchorage dependent cell types, the example here is for hepatocytes because there is a real need to be able to culture functional, more in vivo-like hepatocytes for use in drug development by the pharmaceutical industry and in bioartificial liver devices for the extracorporeal support of liver failure patients. The need for more functional cells extends beyond these examples, particularly as the field of regenerative medicine enters a phase of translational work. The advantages of a more in vivo-like culture environment should not be overlooked.
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